Regeneron stock trades 0.24 percent above its EUR 664.95 Xetra close
Published on 10/10/2026 at 10:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Regeneron stock traded at EUR 666.55 in weekend trading at Lang & Schwarz on October 10, 2026.
- The price was 0.24 percent above the EUR 664.95 close of the last Xetra trading day.
- Regeneron announced 10 oncology-related abstracts for ESMO 2026.
On October 10, 2026, Regeneron stock traded at EUR 666.55 in weekend trading at Lang & Schwarz, up 0.24 percent versus EUR 664.95, the close of the last Xetra trading day.
Market context: Market report S&P 500.
The week in figures
The latest Lang & Schwarz indication was EUR 666.55 at 10:44 a.m. CEST on October 10, 2026. The reference close at Lang & Schwarz was EUR 664.95 on October 9, 2026, putting the weekend price 0.24 percent higher.
The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of Regeneron stock.
Chronology of the week
On October 6, Regeneron announced that it would present new clinical research in 10 abstracts at the European Society for Medical Oncology Congress 2026. The material covers studies in cutaneous squamous cell carcinoma, non-small cell lung cancer, ovarian cancer, melanoma and cancer-associated thrombosis, including late-breaking Phase 3 C-POST survival data for Libtayo. Regeneron’s release said the congress will take place from October 23 through October 27 in Madrid.
Dates of the coming week
The next dated research event identified in the company material is the European Society for Medical Oncology Congress 2026, scheduled for October 23 through October 27. The release lists presentations on Libtayo, investigational oncology programs and Factor XI antibodies. The company announcement provides the presentation schedule.
